Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study

被引:140
作者
Alonso, A. [1 ]
Logroscino, G. [2 ]
Jick, S. S. [3 ]
Hernan, M. A. [4 ,5 ]
机构
[1] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN 55454 USA
[2] Univ Bari, Dept Neurol Sci, Bari, Italy
[3] Boston Univ, Boston Collaborat Drug Surveillance Program, Lexington, MA USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[5] Harvard MIT Div Hlth Sci & Technol, Boston, MA USA
关键词
incidence; lifetime risk; motor neuron disease; AMYOTROPHIC-LATERAL-SCLEROSIS; ALS; MORTALITY; VALIDITY;
D O I
10.1111/j.1468-1331.2009.02586.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To estimate the incidence and lifetime risk of motor neuron disease (MND) in a population-based sample in the United Kingdom. We identified new cases of MND during the period 1990-2005 in the General Practice Research Database, which includes clinical information from more than 3 million Britons enrolled with selected general practitioners. Individuals with a first medical diagnosis of MND recorded in the database were considered incident cases of the disease. The positive predictive value of the computer-based diagnosis was estimated through review of a sample of medical records from potential MND cases. In the period 1990-2005, 830 new cases of MND were identified. Age-standardized incidence of MND was 2.6 per 100 000 persons per year in women (95% CI: 2.3, 2.8) and 3.9 in men (95% CI: 3.6, 4.3). Incidence for both sexes peaked between 75 and 79 years. The rate of MND in men was 54% higher than in women (95% CI: 33%, 77%). The lifetime risk of MND, adjusting for competing causes of death, was 1 in 472 (2.1 per 1000) in women and 1 in 350 (2.9 per 1000) in men. No increase in MND incidence over time was apparent. In this population-based database, we found that MND incidence is higher in men than women, peaking in both sexes between 75 and 79 years.
引用
收藏
页码:745 / 751
页数:7
相关论文
共 27 条
  • [1] [Anonymous], surveillance epidemiology and end results
  • [2] [Anonymous], 1994, J Neurol Sci, V124, P96
  • [3] Armon C., 2004, NEUROEPIDEMIOLOGY PR, P162
  • [4] Sports and trauma in amyotrophic lateral sclerosis revisited
    Armon, Carmel
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 262 (1-2) : 45 - 53
  • [5] Incidence of ALS in Lombardy, Italy
    Beghi, E.
    Millul, A.
    Micheli, A.
    Vitelli, E.
    Logroscino, G.
    [J]. NEUROLOGY, 2007, 68 (02) : 141 - 145
  • [6] El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
    Brooks, BR
    Miller, RG
    Swash, M
    Munsat, TL
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05): : 293 - 299
  • [7] Chiò A, 2001, NEUROLOGY, V56, P239
  • [8] Validity of hospital morbidity records for amyotrophic lateral sclerosis -: A population-based study
    Chiò, A
    Ciccone, G
    Calvo, A
    Vercellino, M
    Di Vito, N
    Ghiglione, P
    Mutani, R
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (07) : 723 - 727
  • [9] Ethnic variation in the incidence of ALS - A systematic review
    Cronin, Simon
    Hardiman, Orla
    Traynor, Bryan J.
    [J]. NEUROLOGY, 2007, 68 (13) : 1002 - 1007
  • [10] Estimating age conditional probability of developing disease from surveillance data
    Fay M.P.
    [J]. Population Health Metrics, 2 (1)